Dr. Barry Dworkin

This new Alzheimer’s drug targets a different brain protein, and requires further evaluation in the research timeline. Further studies required including phase 3 data.

Medical Mythbusting Commentary for July 16, 2026

Source:
This new Alzheimer’s drug targets a different brain protein, and is showing promise

Related posts:

  1. Disease-modifying drug reduces brain protein plaques in Alzheimer patients
  2. Treating high blood pressure may reduce risk of Alzheimers for people with specific genetic marker
  3. Experimental drug reverses of cognitive impairment in Alzheimer mouse model
  4. Alzheimer drug trial failure offers much to learn and should not be seen as a dead end